Manufacturers Life Insurance Company, The Mersana Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 44,473 shares of MRSN stock, worth $72,046. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,473
Previous 46,487
4.33%
Holding current value
$72,046
Previous $93,000
9.68%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding MRSN
# of Institutions
121Shares Held
116MCall Options Held
233KPut Options Held
457K-
Eco R1 Capital, LLC San Francisco, CA19.4MShares$31.4 Million1.59% of portfolio
-
Nextech Invest Ag12.1MShares$19.5 Million3.72% of portfolio
-
Vr Adviser, LLC New York, NY11.3MShares$18.4 Million2.22% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA8.66MShares$14 Million2.94% of portfolio
-
Black Rock Inc. New York, NY8.38MShares$13.6 Million0.0% of portfolio
About Mersana Therapeutics, Inc.
- Ticker MRSN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,169,296
- Market Cap $157M
- Description
- Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...